Literature DB >> 23003570

Pigmented-MDCK (P-MDCK) cell line with tunable melanin expression: an in vitro model for the outer blood-retinal barrier.

Rajendra S Kadam1, Robert I Scheinman, Uday B Kompella.   

Abstract

Retinal pigment epithelium, which forms the outer blood-retinal barrier, is a critical barrier for transport of drugs to the retina. The purpose of this study was to develop a pigmented MDCK (P-MDCK) cell line as a rapidly established in vitro model for the outer blood-retinal barrier to assess the influence of melanin pigment on solute permeability. A melanin synthesizing P-MDCK cell line was developed by lentiviral transduction of human tyrosinase and p-protein genes in MDCK (NBL-2) cells. Melanin content, tyrosinase activity (conversion of L-dopa to dopachrome), and transepithelial electrical resistance (TEER) were measured. Expression of tyrosinase protein and p-protein in P-MDCK cells was confirmed by confocal microscopy. Effect of l-tyrosine (0 to 2 mM) in culture medium on melanin synthesis in P-MDCK cells was evaluated. Cell uptake and transepithelial transport of pigment-binding chloroquine (Log D = 1.59) and a negative control salicylic acid (Log D = -1.14) were investigated. P-MDCK cells expressed tyrosinase and p-protein. Tyrosinase activity was 4.5-fold higher in P-MDCK cells compared to wild type MDCK cells. The transepithelial electrical resistance stabilized by day 4 in both cell types, with the TEER being 958 ± 33 and 964 ± 58 Ω·cm(2) for P-MDCK and wild type cells, respectively. Melanin content in P-MDCK cells depended on the concentration of l-tyrosine in culture medium, and increased from 3 to 54 μg/mg protein with an increase in l-tyrosine content from 0 to 2 mM. When the cells were grown in 2 mM l-tyrosine, uptake of chloroquine was 2.3-fold higher and the transepithelial transport was 2.2-fold lower in P-MDCK cells when compared to wild type MDCK cells. No significant difference was observed for both cell uptake and transport of salicylic acid. We developed a P-MDCK cell line with tunable melanin synthesis as a rapidly developing surrogate for retinal pigment epithelium.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23003570      PMCID: PMC3926804          DOI: 10.1021/mp300305f

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  40 in total

1.  Pink-eyed dilution protein controls the processing of tyrosinase.

Authors:  Kun Chen; Prashiela Manga; Seth J Orlow
Journal:  Mol Biol Cell       Date:  2002-06       Impact factor: 4.138

2.  Ex vivo models to evaluate the role of ocular melanin in trans-scleral drug delivery.

Authors:  Silvia Pescina; Patrizia Santi; Giulio Ferrari; Cristina Padula; Pierugo Cavallini; Paolo Govoni; Sara Nicoli
Journal:  Eur J Pharm Sci       Date:  2012-03-30       Impact factor: 4.384

3.  Safety of submacular suprachoroidal drug administration via a microcatheter: retrospective analysis of European treatment results.

Authors:  Manfred Tetz; Stanislao Rizzo; Albert J Augustin
Journal:  Ophthalmologica       Date:  2012-02-21       Impact factor: 3.250

4.  Sclera-choroid-RPE transport of eight β-blockers in human, bovine, porcine, rabbit, and rat models.

Authors:  Rajendra S Kadam; Narayan P S Cheruvu; Henry F Edelhauser; Uday B Kompella
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-23       Impact factor: 4.799

5.  Suprachoroidal drug infusion for the treatment of severe subfoveal hard exudates.

Authors:  Stanislao Rizzo; Federica Genovesi Ebert; Emanuele Di Bartolo; Francesco Barca; Federica Cresti; Constanze Augustin; Albert Augustin
Journal:  Retina       Date:  2012-04       Impact factor: 4.256

6.  Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.

Authors:  Chirag P Shah; Sunir J Garg; James F Vander; Gary C Brown; Richard S Kaiser; Julia A Haller
Journal:  Ophthalmology       Date:  2011-06-25       Impact factor: 12.079

7.  Correlation between rod photoreceptor numbers and levels of ocular pigmentation.

Authors:  Philippe Donatien; Glen Jeffery
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-04       Impact factor: 4.799

8.  The etiology of oculocutaneous albinism (OCA) type II: the pink protein modulates the processing and transport of tyrosinase.

Authors:  Kazutomo Toyofuku; Julio C Valencia; Tsuneto Kushimoto; Gertrude-E Costin; Victoria M Virador; Wilfred D Vieira; Victor J Ferrans; Vincent J Hearing
Journal:  Pigment Cell Res       Date:  2002-06

Review 9.  Recent advances in ophthalmic drug delivery.

Authors:  Uday B Kompella; Rajendra S Kadam; Vincent H L Lee
Journal:  Ther Deliv       Date:  2010-09

10.  Tyrosinase and tyrosinase-related protein 1 require Rab7 for their intracellular transport.

Authors:  Kuninori Hirosaki; Toshiharu Yamashita; Ikuo Wada; Hai-Ying Jin; Kowichi Jimbow
Journal:  J Invest Dermatol       Date:  2002-08       Impact factor: 8.551

View more
  3 in total

1.  Alternating magnetic field-induced hyperthermia increases iron oxide nanoparticle cell association/uptake and flux in blood-brain barrier models.

Authors:  Mo Dan; Younsoo Bae; Thomas A Pittman; Robert A Yokel
Journal:  Pharm Res       Date:  2014-11-07       Impact factor: 4.200

2.  Exploration of the Plausible Mechanism of Ethambutol Induced Ocular Toxicity by Using Proteomics Informed Physiologically Based Pharmacokinetic (PBPK) Modeling.

Authors:  Ankit Balhara; Mayur K Ladumor; Rakesh P Nankar; Samiulla Dodheri Syed; Sanjeev Giri; Bhagwat Prasad; Saranjit Singh
Journal:  Pharm Res       Date:  2022-03-17       Impact factor: 4.200

3.  Comparison of transepithelial resistance measurement techniques: Chopsticks vs. Endohm.

Authors:  Rebecca A Sheller; Maria E Cuevas; Maria C Todd
Journal:  Biol Proced Online       Date:  2017-05-10       Impact factor: 3.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.